Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living‐donor liver transplant recipients

M Fukudo, I Yano, S Masuda, M Goto… - Clinical …, 2006 - Wiley Online Library
Objective Our objective was to investigate the population pharmacokinetics of tacrolimus in
pediatric living‐donor liver transplant recipients and examine the effects of the multidrug …
被引用次数：151 相关文章

Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.

M Fukudo, I Yano, S Masuda, M Goto… - Clinical …, 2006 - europepmc.org
Objective Our objective was to investigate the population pharmacokinetics of tacrolimus in
pediatric living-donor liver transplant recipients and examine the effects of the multidrug …

[引用][C] Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients

M FUKUDO, I YANO, S UEMOTO… - Clinical …, 2006 - pascal-francis.inist.fr
Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor
liver transplant recipients CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients*.

M Fukudo, I Yano, S Masuda, M Goto… - Clinical …, 2006 - search.ebscohost.com
Objective: Our objective was to investigate the population pharmacokinetics of tacrolimus in
pediatric living-donor liver transplant recipients and examine the effects of the multidrug …

Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients

M Fukudo, I Yano, S Masuda, M Goto, M Uesugi… - Clinical Pharmacology & …, 2006 - infona.pl
Our objective was to investigate the population pharmacokinetics of tacrolimus in pediatric
living-donor liver transplant recipients and examine the effects of the multidrug resistance 1 …

Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients

M Fukudo, I Yano, S Masuda, M Goto… - Clinical …, 2006 - pubmed.ncbi.nlm.nih.gov
Objective Our objective was to investigate the population pharmacokinetics of tacrolimus in
pediatric living-donor liver transplant recipients and examine the effects of the multidrug …

[引用][C] Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients

M FUKUDO - Clin. Pharmacol. Ther., 2006 - cir.nii.ac.jp
Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor
liver transplant recipients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients

M Fukudo, I Yano, S Masuda… - Clinical …, 2006 - kyushu-u.elsevierpure.com
Objective: Our objective was to investigate the population pharmacokinetics of tacrolimus in
pediatric living-donor liver transplant recipients and examine the effects of the multidrug …

[引用][C] Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients

M FUKUDO - Clin. Pharmacol. Ther., 2006 - cir.nii.ac.jp
Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor
liver transplant recipients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients

M Fukudo, I Yano, S Masuda, M Goto, M Uesugi… - Clinical Pharmacology & …, 2006 - infona.pl
Our objective was to investigate the population pharmacokinetics of tacrolimus in pediatric
living-donor liver transplant recipients and examine the effects of the multidrug resistance 1 …